Treatment of Gastritis Flare-Up
Start high-potency proton pump inhibitors (PPIs) immediately at twice-daily dosing—specifically esomeprazole 20-40 mg twice daily or rabeprazole 20 mg twice daily, taken 30 minutes before meals—as first-line treatment for rapid symptom relief and mucosal healing. 1, 2, 3
Immediate Management
PPI Selection and Dosing
- Esomeprazole 20-40 mg twice daily (equivalent to 32 mg omeprazole) is the preferred high-potency option 1, 2
- Rabeprazole 20 mg twice daily (equivalent to 36 mg omeprazole) is equally effective 1, 2
- Lansoprazole 30 mg twice daily (equivalent to 27 mg omeprazole) is an alternative 1
- Avoid pantoprazole when possible due to significantly lower potency (40 mg pantoprazole = only 9 mg omeprazole) 1
- Critical timing: Take PPIs 30 minutes before meals for optimal effectiveness 2, 3
Adjunctive Symptom Relief
- Add antacids for rapid, temporary relief of breakthrough symptoms on-demand 1, 2, 3
- These provide immediate symptomatic relief while PPIs work to heal the mucosa 1
Essential H. pylori Assessment
Test all gastritis patients for H. pylori infection using non-invasive methods (urea breath test or monoclonal stool antigen test) rather than serology 1, 3
If H. pylori Positive
- Bismuth quadruple therapy for 14 days is the preferred first-line treatment due to increasing clarithromycin resistance: PPI + bismuth + metronidazole + tetracycline 1, 2, 3
- Concomitant 4-drug therapy is an alternative when bismuth is unavailable 1, 2
- Use antibiotics from the "Access group" (amoxicillin, tetracycline, metronidazole) rather than "Watch group" antibiotics when possible to minimize resistance 3
- Higher-potency PPIs (esomeprazole or rabeprazole) improve H. pylori eradication rates 1
- Confirm eradication 4-6 weeks after completing therapy using non-serological testing 3
- For bleeding ulcers, start H. pylori eradication treatment when oral feeding is reintroduced 4
If H. pylori Negative
- Continue full-dose PPI therapy for 4-8 weeks 1, 2
- Gradual improvement with fluctuations is expected 2
NSAID-Related Gastritis
- Discontinue NSAIDs immediately if possible 3
- If NSAIDs must be continued, use the lowest effective dose for the shortest duration 1, 2
- Add PPI therapy for gastroprotection in all high-risk patients taking NSAIDs 1, 2
- Test and eradicate H. pylori before starting long-term NSAID therapy, especially in patients with prior peptic ulcer history 1, 3
- Misoprostol reduces NSAID-associated gastric ulcers by 74% but causes diarrhea and abdominal pain in many patients 1, 2
Duration and Follow-Up
- Continue PPI therapy for 4-8 weeks for initial healing 2, 5
- For gastric ulcers, continue PPI treatment until complete healing is confirmed by endoscopy 4
- For complicated ulcers, continue PPI until H. pylori eradication is confirmed 4
- If symptoms persist despite 8 weeks of treatment, consider an additional 4 weeks 5
Critical Pitfalls to Avoid
- Never use antibiotic therapy <14 days duration as this significantly reduces H. pylori eradication rates 3
- Do not rely on symptom resolution alone—confirm H. pylori eradication with non-serological testing 1, 3
- Inadequate PPI dosing (wrong timing relative to meals) reduces effectiveness dramatically 1, 2
- Premature discontinuation of treatment before mucosal healing is complete 1
- Failure to address underlying H. pylori infection when present 1
- Using serology to confirm eradication (remains positive after successful treatment) 3
Special Considerations for Atrophic Gastritis
If atrophic gastritis is present on histology: